FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy such as FR901228 use different ways to stop cancer cells from
dividing so they stop growing or die. Phase II trial to study the effectiveness of FR901228
in treating patients who have relapsed or refractory multiple myeloma